Description: This article provides an overview of critical illness insurance: history, product description, and the three primary ways to offer critical illness coverage in the United States. This article also contains an illustration of an issue age premium rate calculation, as well as product features and rating applications specific to the various types of critical illness coverage.

Description: Critical Illness Insurance is one of the fastest growing insurance products available today. Carriers continue to introduce innovative approaches in second, third, and fourth generation products while refining their pricing, underwriting, and claims adjudication processes. This session will look back at historical trends using Gen Re's longstanding, comprehensive Critical Illness Market Survey, and look forward to potential market changes to occur in the next 18 months.

Description: The last three decades have witnessed an important rise in number of people with diabetes in Asia, especially Type 2 Diabetes. Like no other common condition, numerous innovations are currently entering the healthcare system that will soon have a significant impact on management of the condition. This presentation explores the role played by sensors/wearables, artificial intelligence, new drugs and diabetes apps. We assess the realistic potential of such advancements and give an outlook on medium-term pricing and product development.

Description: Health Watch, Issue 79, December 2015, Health Watch

Description: Critical illness CI products are gaining in popularity in North America. These products have been available for close to 20 years in many countries around the world, including South Africa, Australia, the United Kingdom and most of Asia. Many of the lessons learned in these countries concerning product design, pricing, underwriting and claims adjudication are relevant to the U.S. market. This session reviews the latest trends around the world. Attendees gain insight into the key issues driving the profitability of the product and are better positioned to determine the main considerations in deciding whether or not to introduce such a product in their market. From the Record of the Society of Actuaries, Volume 29, No. 1, Washington, D.C., Spring Meeting, May 29–30, 2003, Session 60PD.

Description: Panelists address current issues of critical illness products including underwriting, state filing, distribution and marketing. From the Record of the Society of Actuaries, Volume 28, No. 1, Session 33